Antigen-induced reduction in mast cell and basophil functional responses due to reduced Syk protein levels

被引:60
作者
Kepley, CL [1 ]
机构
[1] Virginia Commonwealth Univ Hlth Syst, Dept Internal Med, Div Rheumatol Allergy & Immunol, Richmond, VA 23298 USA
关键词
mast cells/basophil; IgE; Fc epsilon RI; signal transduction; desensitization;
D O I
10.1159/000087355
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: The high-affinity IgE receptor, Fc epsilon RI, is unresponsive on mast cells and basophils from people in several populations through an unknown mechanism. Similarly, Fc epsilon RI-positive basophils from 'nonreleasers' are IgE-unresponsive and are deficient in the tyrosine kinase Syk. Objective: To test the hypothesis that cross-linking Fc epsilon RI on mast cells and basophils leads to Fc epsilon RI nonresponsiveness through reduction in Syk protein levels. Methods: Human mast cells and basophils were used to determine if Fc epsilon RI hyporesponsiveness correlated with reduced Syk levels. Results: It is shown that suboptimal antigen challenge, that did not lead to significant mediator release, induced nonresponsiveness and correlated with reduced Syk. Other IgE-associated signaling molecules were unaffected by the same treatment. The ability of IgE-unresponsive mast cells to regain Fc epsilon RI responsiveness is paralleled by increased cellular Syk levels in vitro. The reduction of Syk levels with suboptimal antigen concentrations was calcium independent and mediated through a proteasome-dependent mechanism. Conclusion: These findings confirm and extend our knowledge about a novel regulatory mechanism for maintaining Fc epsilon RI in a quiescent state. This mechanism may also explain why low concentrations of allergen given to patients during allergen immunotherapy induce Fc epsilon RI nonresponsiveness and therapeutic benefit without inducing systemic anaphylaxis. Copyright (C) 2005 S. Karger AG, Basel.
引用
收藏
页码:29 / 39
页数:11
相关论文
共 38 条
[1]   Mechanisms of allergen-specific immunotherapy [J].
Akdis, CA ;
Blaser, K .
ALLERGY, 2000, 55 (06) :522-530
[2]   DOUBLE-BLIND, PLACEBO-CONTROLLED IMMUNOTHERAPY WITH MIXED GRASS-POLLEN ALLERGOIDS .2. COMPARISON BETWEEN PARAMETERS ASSESSING THE EFFICACY OF IMMUNOTHERAPY [J].
BOUSQUET, J ;
MAASCH, H ;
MARTINOT, B ;
HEJJAOUI, A ;
WAHL, R ;
MICHEL, FB .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1988, 82 (03) :439-446
[3]  
Costello PS, 1996, ONCOGENE, V13, P2595
[4]   DOSE-RESPONSE OF IGE AND IGG ANTIBODIES DURING RAGWEED IMMUNOTHERAPY [J].
CRETICOS, PS ;
VANMETRE, TE ;
MARDINEY, MR ;
ROSENBERG, GL ;
NORMAN, PS ;
ADKINSON, NF .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1984, 73 (01) :94-104
[5]   IMMUNOTHERAPY IN ASTHMA [J].
CRETICOS, PS .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1989, 83 (02) :554-562
[6]  
Gruchalla R. S., 2003, J ALLERGY CLIN IM S2, V111, P548
[7]   Ubiquitin-mediated degradation of active Src tyrosine kinase [J].
Harris, KF ;
Shoji, I ;
Cooper, EM ;
Kumar, S ;
Oda, H ;
Howley, PM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (24) :13738-13743
[8]   Involvement of Bruton's tyrosine kinase in FcεRI-dependent mast cell degranulation and cytokine production [J].
Hata, D ;
Kawakami, Y ;
Inagaki, N ;
Lantz, CS ;
Kitamura, T ;
Khan, WN ;
Maeda-Yamamoto, M ;
Miura, T ;
Han, W ;
Hartman, SE ;
Yao, L ;
Nagai, H ;
Goldfeld, AE ;
Alt, FW ;
Galli, SJ ;
Witte, ON ;
Kawakami, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (08) :1235-1247
[9]  
KAGEYSOBOTKA A, 1982, FED PROC, V41, P12
[10]   Human skin-derived mast cells can proliferate while retaining their characteristic functional and protease phenotypes [J].
Kambe, N ;
Kambe, M ;
Kochan, JP ;
Schwartz, LB .
BLOOD, 2001, 97 (07) :2045-2052